摘要
目的评价3种呼吸困难评分工具在我国慢性阻塞性肺疾病(简称慢阻肺)患者中应用的临床价值。方法选择2012年1月至2014年12月在河南省胸科医院呼吸科就诊的稳定期慢阻肺患者66例,采用医学研究会呼吸困难量表(MRC)、氧值图解(OCD)和基础呼吸困难指数(BDI)行呼吸困难评分,采用中文版医学结局调查(SF-36)行生活质量评估,并行肺功能测试。结果 3种呼吸困难评分相互之间有较强相关性(r值为-0.855~0.915);3种呼吸困难评分和年龄、身高及体重之间无明显相关性;MRC、OCD及BDI分别和用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、残气肺总量比及一氧化碳弥散量有显著相关性(r值为-0.269^-0.461),与FEV1/FVC无明显相关性;3种呼吸困难评分均与SF-36除情感职能及精神健康以外的6个部分有显著相关性,肺功能指标和SF-36的生理功能和情感职能2个部分有较强相关性,呼吸困难评分与生活质量的相关性较肺功能指标与生活质量的相关性明显。结论 3种呼吸困难评分与其他生理及临床指标具有较好的相关性,值得临床推广。
Objective To evaluate the clinical value of three clinical methods for rating dyspnea in chronic obstructive pulmonary disease （COPD）. Methods Sixty-six patients with stable COPD visiting the respiratory department between January 2012 and December 2014 were recruited in the study. Quality of life was assessed by the Chinese version SF-36, and dyspnea was assessed by the medical research council scale （MRC）, oxygen-cost diagram （OCD） and baseline dyspnea index （BD!）, respectively. All patients underwent pulmonary function test. Results Dyspnea scores from all three methods were significantly correlated （r value ranged from -0. 855 to 0. 915 ）, but they had no correlation with height, age or weight. Dyspnea scores obtained from the MRC, OCD and BDI correlated significantly with FVC, FEV1 , RV/TLC and DLCO（r value ranged from 0. 269 to -0. 461 ） ,but not obviously correlated with FEV1/FVC. Three dyspnea scores were all significantly correlated with six components of the SF-36, except the role limitations due to emotional problems and mental healthy. The spirometic values were significantly correlated with two components of the SF-36, including physical functioning and role limitations due to emotional problem. Dyspnea had more closely correlation with the life quality than the spirometic values. Conclusion Three methods for rating dyspnea show good consistency with different physiological index.
出处
《中国呼吸与危重监护杂志》
CAS
北大核心
2015年第3期269-272,共4页
Chinese Journal of Respiratory and Critical Care Medicine
关键词
慢性阻塞性肺疾病
呼吸困难
肺功能
生活质量
评价
Chronic obstructive pulmonary disease
Dyspnea
Pulmonary function
Quality oflife
Evaluation
